Angiogenic and EGFR Blockade With Curative Chemoradiation for Advanced Head and Neck Cancer
Sponsor and Collaborators
Duke University
Genentech
OSI Pharmaceuticals
Contact
David M Brizel, MD
919-668-5637
david.brizel@duke.edu
Clinical Trials
919-668-3726
madeline.carroll@duke.edu
Principal Investigator
David M Brizel, MD
Department of Radiation Oncology; Duke University Medical Center
Clinical Trials.gov Identifier
NCT00140556
